Mycoplasma genitalium is a sexually transmitted bacterium that can infect the urethra, the tube that carries urine and semen through the penis. In men, it is best known for causing urethritis, which can lead to burning when peeing, penile discharge, irritation at the tip of the penis, or symptoms that keep coming back after treatment for chlamydia or gonorrhea. Some men have no symptoms at all.
This infection needs careful handling because standard STI testing does not always include it, and common antibiotics may fail when the strain is resistant. Taking leftover antibiotics or repeating the same treatment can make the problem harder to clear. The usual next steps are targeted testing, resistance-aware treatment, partner care, and the right timing for follow-up testing when it is needed.
Table of Contents
- What Mycoplasma Genitalium Is and How Men Get It
- Symptoms in Men and What They Can Feel Like
- When to Test and Why Routine STI Panels May Miss It
- Why Antibiotic Resistance Changes Treatment
- Treatment Options and What the Timeline Usually Looks Like
- Sex, Partners, Reinfection, and Test-of-Cure Timing
- Conditions That Can Look Similar
- Prevention and Follow-Up Steps After Symptoms Improve
What Mycoplasma Genitalium Is and How Men Get It
Mycoplasma genitalium, often shortened to M. genitalium or MG, is a small bacterium that spreads mainly through sexual contact. It can infect the urethra in men and the cervix or upper reproductive tract in women. It can also be found in rectal samples, especially after receptive anal sex, although the role it plays in rectal symptoms is less clear than its role in urethritis.
It is not the same as chlamydia, gonorrhea, herpes, HPV, or trichomoniasis. It can cause symptoms that overlap with other STIs, but it needs its own test and often a different treatment plan.
Transmission is most likely during:
- Vaginal sex
- Anal sex
- Genital-to-genital contact with infected fluids
- Sharing sex toys without cleaning or barrier protection
Oral transmission is less well understood. MG is not spread by toilet seats, casual touch, sharing towels, or using the same shower.
One detail makes this infection harder to manage: it has no cell wall. Some antibiotics work by attacking bacterial cell walls, so those drugs are not useful against MG. That is one reason treatment choices are narrower than they are for many common infections.
In men, MG is strongly linked with non-gonococcal urethritis, which means urethral inflammation not caused by gonorrhea. It is also a common reason symptoms continue after a man tests negative for gonorrhea and chlamydia or after standard treatment does not fully work.
Having MG does not mean someone did anything unusual. It is an STI, and many people with STIs have no symptoms. A man can carry it without knowing, pass it to a partner, then develop symptoms later or never develop symptoms at all.
Symptoms in Men and What They Can Feel Like
The most common pattern in men is mild to moderate urethral irritation that does not feel severe enough for the emergency room but does not go away. Some men notice symptoms only in the morning; others feel burning every time they urinate.
Common symptoms include:
- Burning, stinging, or discomfort when peeing
- Watery, cloudy, or mucus-like discharge from the penis
- Irritation, itching, or tingling inside the urethra
- Redness or soreness at the tip of the penis
- A feeling that urine is irritating the urethra
- Discomfort after sex or ejaculation
- Symptoms that return after temporary improvement
Discharge can be light and easy to miss. It may show up as a small clear spot in underwear, a sticky feeling at the opening of the penis, or fluid that appears only when the urethra is gently “milked.” A more obvious yellow or green discharge can happen with other infections too, so testing matters. A separate guide to penile discharge and STI testing can help explain why color alone is not enough to identify the cause.
MG symptoms can appear similar to chlamydia. They can also overlap with gonorrhea, but gonorrhea more often causes thicker, pus-like discharge and more intense burning. Still, symptoms are not reliable enough to tell these infections apart. Men with burning or discharge often need testing for several infections at the same visit, including chlamydia and gonorrhea. Men comparing symptoms may also find it helpful to understand how chlamydia symptoms in men can overlap with other causes of urethritis.
Some men have no symptoms. Others have symptoms that come and go. A temporary improvement does not always mean the infection is gone, especially if antibiotics reduced the bacterial load without clearing it.
Symptoms outside the urethra are less straightforward. MG has been studied in relation to epididymitis, prostatitis-like symptoms, and pelvic discomfort, but the clearest link in men is still urethritis. Testicular pain, swelling, fever, or severe pelvic pain should not be assumed to be MG. Those symptoms need prompt medical evaluation because other problems can be more urgent.
When to Test and Why Routine STI Panels May Miss It
A standard STI check often tests for chlamydia, gonorrhea, HIV, syphilis, and sometimes trichomoniasis, but not always MG. Many men assume “my STI tests were negative” means MG was ruled out. Often, it was never tested.
Testing is most useful when a man has:
- Persistent or recurrent urethritis
- Burning or discharge with negative chlamydia and gonorrhea tests
- Symptoms that continue after standard urethritis treatment
- A sex partner who tested positive for MG
- Ongoing symptoms after a new sexual exposure
- A clinician who suspects MG based on symptoms and local resistance patterns
Routine screening of men with no symptoms is not generally recommended in many guidelines. The reason is not that MG is harmless. It is because the meaning of asymptomatic infection is not always clear, antibiotic options are limited, and unnecessary treatment can add to resistance.
The preferred test is a nucleic acid amplification test, usually called a NAAT. This test looks for MG genetic material. For men, the sample is often first-catch urine, meaning the first part of the urine stream, not a midstream clean-catch urine sample. Some clinics may use urethral, penile-meatal, rectal, or other swabs depending on symptoms and exposure sites.
A regular urine culture usually will not diagnose MG. The bacterium grows very slowly and is not handled like a routine UTI germ. A dipstick urine test may show inflammation, but it cannot identify MG.
Timing also matters. Testing too early after exposure can miss an infection before there is enough organism to detect. There is no perfect waiting period for every situation, but men with symptoms should not delay care just to meet a testing window. Men without symptoms after an exposure should ask a clinician or sexual health clinic when testing makes sense for their situation. For broader STI timing questions, see when to get STI tested after exposure.
At-home STI tests may or may not include MG. The label should clearly say “Mycoplasma genitalium” or “M. genitalium.” Some kits test only chlamydia and gonorrhea even when marketed as a broad panel. Men using home collection should confirm which infections are included, what sample type is required, and whether positive results include access to medical treatment. A separate article on at-home STI tests for men explains how to read kit claims and timing limits.
Resistance testing is different from diagnosis. A diagnostic test says whether MG is present. Resistance testing looks for mutations that predict whether azithromycin, a macrolide antibiotic, is likely to fail. Access varies by country, clinic, and laboratory. When resistance testing is available, it can help avoid the wrong antibiotic.
Why Antibiotic Resistance Changes Treatment
MG is not treated like a simple one-dose infection anymore. Resistance to macrolide antibiotics, especially azithromycin, is common in many regions. Fluoroquinolone resistance, which can affect moxifloxacin, is also a concern. Dual resistance is less common but more difficult.
Resistance means the bacteria have genetic changes that make an antibiotic less likely to work. It does not mean the man’s body is resistant, and it does not mean he did anything wrong. It means the organism may survive a drug that used to clear many infections.
Single-dose azithromycin is a major mistake for suspected or confirmed MG. It may reduce symptoms for a while, but it can fail and may select for resistant strains. Repeating azithromycin without testing can make later treatment harder.
Doxycycline is often used first, but it usually is not enough by itself to cure MG. Its role is to lower the amount of bacteria before the second antibiotic. Lower bacterial load can improve the chance that the next medication works and may reduce the chance of selecting resistance.
Resistance-aware care usually follows one of two approaches:
| Situation | Why it matters | Typical approach |
|---|---|---|
| MG positive and macrolide-sensitive | Azithromycin is more likely to work when resistance mutations are absent. | Doxycycline first, then an extended azithromycin regimen. |
| MG positive and macrolide-resistant | Azithromycin is likely to fail. | Doxycycline first, then moxifloxacin if appropriate. |
| MG positive but resistance testing unavailable | The clinician cannot confirm whether azithromycin will work. | Doxycycline first, then moxifloxacin is commonly recommended in U.S. guidance. |
| Persistent positive test after treatment | Reinfection, missed doses, wrong antibiotic, or resistance may be involved. | Specialist input and careful review of partner treatment and test timing. |
Moxifloxacin can be effective, but it is not a casual antibiotic. It belongs to the fluoroquinolone class, which can have important side effects, including tendon problems, nerve symptoms, mood or sleep changes, heart rhythm concerns in susceptible people, and drug interactions. The risk is not the same for every man, but it should be prescribed with a clear reason.
Men should tell the clinician about:
- Heart rhythm problems or prolonged QT interval
- Tendon disorders or past fluoroquinolone reactions
- Nerve pain, neuropathy, or severe medication side effects
- Current medications and supplements
- Liver or kidney disease
- Severe anxiety, insomnia, or mood reactions to medications
Treatment failure does not always mean resistance. Missed doses, vomiting after a dose, sex with an untreated partner, testing too soon after treatment, or taking antibiotics in the wrong order can all confuse the picture.
Treatment Options and What the Timeline Usually Looks Like
Treatment usually starts after MG is confirmed, especially when symptoms are persistent or recurrent. In some settings, a clinician may treat based on a strong suspicion when testing is unavailable and other infections have been reasonably ruled out.
A common U.S. treatment pattern is two-stage therapy:
- Doxycycline 100 mg twice daily for 7 days.
- A second antibiotic based on resistance results or local guidance.
When macrolide resistance testing is available and the strain is macrolide-sensitive, the second step may be extended azithromycin: 1 gram once, followed by 500 mg daily for 3 more days. This is not the same as the older one-dose azithromycin approach.
When the strain is macrolide-resistant, or when resistance testing is unavailable in many U.S. settings, the second step is often moxifloxacin 400 mg once daily for 7 days. Longer courses may be used for complicated infections or specific clinical situations.
Men should follow the exact regimen given by their clinician. Small changes can matter. Stopping when symptoms improve, skipping doses, taking doses at random times, or saving pills “just in case” can raise the chance of failure.
Symptoms may begin improving during doxycycline or shortly after the second antibiotic starts. Burning often improves before irritation fully settles. The urethra can remain sensitive for a short period after bacteria are cleared, especially if symptoms lasted for weeks.
A rough timeline may look like this:
- Days 1–7: Doxycycline lowers bacterial load. Some symptoms may ease, but this does not prove cure.
- Days 8–14 or longer: The second antibiotic targets clearance.
- First 1–2 weeks after treatment: Mild irritation can continue while inflammation settles.
- Three or more weeks after treatment: If a test-of-cure is needed, testing is usually delayed until this point to avoid misleading results.
Do not drink alcohol heavily during treatment. Alcohol may not directly inactivate every antibiotic used for MG, but it can worsen side effects, increase missed doses, and make it harder to tell whether nausea, dizziness, or other symptoms are medication-related.
Doxycycline can irritate the esophagus and increase sun sensitivity. It is usually taken with a full glass of water, and men are often advised not to lie down right after taking it. Dairy, calcium, iron, magnesium, and antacids can reduce absorption if taken too close to the dose, so spacing instructions matter.
Moxifloxacin should be taken exactly as prescribed. Men should ask what side effects require stopping the drug and calling the prescriber. New tendon pain, severe diarrhea, fainting, irregular heartbeat, severe mood changes, or nerve symptoms such as burning, tingling, or numbness deserve urgent advice.
Treatment is not only about pills. A successful plan also includes partner management, avoiding reinfection, and follow-up if symptoms do not resolve.
Sex, Partners, Reinfection, and Test-of-Cure Timing
Reinfection is common when partners are not tested or treated. A man can complete the right medication, feel better, have sex with an untreated partner, and get infected again. This can look like treatment failure even when the antibiotic worked.
Current sexual partners should be told about the diagnosis. Clinics may recommend that partners be tested and treated if positive. If partner testing is not possible, some clinicians treat partners based on the index patient’s diagnosis and local guidance. The exact approach can vary because evidence is still developing.
Sex should usually be avoided until:
- The man has completed treatment.
- Partners have been tested or treated as advised.
- Symptoms have resolved or clearly improved.
- The clinician’s waiting period has passed.
Condoms lower the risk of passing MG and other STIs, but they must be used from the start of sex and with the right fit. Men who have had condom breaks, slipping, or inconsistent use may benefit from reviewing common condom mistakes and fit problems.
A test of cure means repeat testing after treatment to confirm the infection is gone. In U.S. practice, it is not always required for men who have no symptoms after a recommended regimen. It is more likely to be recommended when:
- Symptoms continue after treatment.
- A nonpreferred regimen was used.
- Resistance testing was unavailable and there is concern for failure.
- Moxifloxacin could not be used.
- There is a high risk of reinfection.
- A partner is pregnant or has ongoing symptoms.
- The clinic follows a protocol that checks all treated MG cases.
Testing too soon can create confusion. NAATs can sometimes detect leftover genetic material after bacteria are no longer active. Many guidelines advise waiting at least 21 days, or about 3 weeks, after completing treatment before test-of-cure sampling.
If the test remains positive, the next step is not to repeat the same antibiotic automatically. The clinician should review the original test, medication timing, missed doses, sex during treatment, partner care, and whether resistance testing is available. Persistent cases may need a sexual health specialist or urologist familiar with resistant MG.
Conditions That Can Look Similar
Burning, discharge, and urethral irritation do not point to one infection every time. MG is one cause, but several other conditions can look similar.
Chlamydia is one of the most common causes of urethritis in men. It can cause burning and watery discharge, and some men have no symptoms. Gonorrhea can cause similar symptoms but often produces thicker discharge and more intense pain. Men should not rely on symptom pattern alone. A guide to gonorrhea symptoms in men explains why prompt testing matters when discharge is heavier or symptoms are more severe.
Trichomoniasis can also cause urethral irritation, though many men have no symptoms. It is more common in some populations and locations than others. If symptoms continue and MG, chlamydia, and gonorrhea are negative, clinicians may consider trichomoniasis testing and partner care.
Ureaplasma is another organism that can show up on genital testing, but it is not handled the same way as MG. Some Ureaplasma species can be present without causing disease, so a positive result does not always mean it needs treatment. Men with confusing test panels may want to understand when Ureaplasma matters in men before assuming every positive finding needs antibiotics.
Other possibilities include:
- Urinary tract infection
- Prostatitis or chronic pelvic pain syndrome
- Chemical irritation from soaps, lubricants, or spermicides
- Friction from sex or masturbation
- Herpes, especially when pain occurs with sores or ulcers
- Balanitis, especially with redness, itching, or rash on the head of the penis
- Kidney stone irritation if pain and blood in urine are present
Some symptoms should be handled urgently rather than managed as routine urethritis. Get prompt medical care for:
- Testicular pain or swelling
- Fever, chills, or feeling very ill
- Severe pelvic, flank, or abdominal pain
- Blood in urine
- Inability to urinate
- Painful sores or blisters
- A swollen, trapped foreskin
- New joint pain with eye redness or rash after an STI-like illness
Testicular torsion, severe epididymitis, urinary retention, and kidney stones need different care. Waiting to see whether STI antibiotics help can be risky when symptoms are severe or sudden.
Prevention and Follow-Up Steps After Symptoms Improve
Symptoms improving is a good sign, but it should not be the only measure of success. The safest follow-up depends on the treatment used, whether partners were treated, and whether symptoms fully resolved.
Men can reduce the chance of recurrence by taking several clear steps:
- Finish the full antibiotic course exactly as prescribed.
- Avoid sex until the clinician’s recommended waiting period is over.
- Make sure recent partners are notified, tested, or treated.
- Use condoms consistently with new or untested partners.
- Return for follow-up if burning, discharge, or irritation persists.
- Avoid taking leftover antibiotics after future exposures.
- Keep a record of the MG treatment used in case symptoms return.
Follow-up is especially important if symptoms improve but do not fully disappear. Mild urethral sensitivity can linger for a short time, but ongoing discharge, worsening burning, or symptoms that return after sex need reassessment.
Men with repeated urethritis should ask whether testing included:
- Chlamydia
- Gonorrhea
- MG
- Trichomoniasis when relevant
- HIV and syphilis based on exposure risk
- Urinalysis or urine culture if UTI is possible
Prevention is not only about condoms. It also includes reducing delays in testing, avoiding sex while symptoms are active, discussing STI status with partners, and retesting when a clinician recommends it. Men with new or multiple partners may need a broader STI testing plan rather than waiting for symptoms each time.
It is also worth separating MG from long-term anxiety about sexual health. After proper treatment and follow-up, many men clear the infection and do not have lasting problems. Ongoing genital discomfort after negative follow-up tests may come from pelvic floor tension, nerve sensitivity, skin irritation, prostatitis-like pain, or anxiety-driven checking. That does not mean symptoms are “imaginary.” It means the next evaluation may need to look beyond infection.
References
- Mycoplasma genitalium – STI Treatment Guidelines 2021 (Guideline)
- Mycoplasma genitalium Management in Adults 2022 (Guideline)
- 2021 European guideline on the management of Mycoplasma genitalium infections 2022 (Guideline)
- British Association of Sexual Health and HIV National guideline for the management of infection with Mycoplasma genitalium, 2025 2025 (Guideline)
- Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis 2025 (Systematic Review)
Disclaimer
This article is educational and should not replace care from a qualified clinician. Mycoplasma genitalium testing, antibiotic choice, partner treatment, and test-of-cure timing should be guided by a healthcare professional, especially when symptoms persist or resistance is suspected. Seek urgent care for severe testicular pain, fever, inability to urinate, blood in urine, or rapidly worsening symptoms.
